Biotech RadarJobs updated

COMPANY

Latigo Biotherapeutics

HQ: Thousand Oaks, CA source · latigobio.com ↗ · West Coast

Clinical Phase 2

19 open jobs · last seen Oct 23, 2026 · 8 sources

Keywords: osteoarthritis Pain Detection Pain Threshold Postoperative Acute Pain Acute Pain Postoperative Pain Control Pain Management LTG-321 LTG-001 LTG-305

Location: Thousand Oaks, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

19Open jobs8Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Associate Director, ToxicologySan Francisco, CaliforniaNot statedOct 16, 2026
Associate Director, Clinical PharmacologySan Francisco, CaliforniaNot statedOct 16, 2026
Vice President / Senior Vice President, Human ResourcesSan Francisco, CaliforniaNot statedOct 16, 2026
Senior Director, Patient Safety & PharmacovigilanceSan Francisco, CaliforniaNot statedOct 16, 2026
Associate Director/Principal Scientist, CMC Analytical ChemistrySan Francisco, CaliforniaNot statedOct 16, 2026

See all 19 jobs

Timeline

  1. Trial start Phase 1: A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants source ↗
  2. Trial start 1: Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants source ↗
  3. Trial start Phase 2: An Efficacy and Safety Study of LTG-001 Following Abdominoplasty source ↗
  4. Trial start Early phase 1: Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults source ↗
  5. Trial start Phase 2: This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars source ↗
  6. Trial start Early phase 1: Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults source ↗
  7. Trial start 1: A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants source ↗
  8. Trial start 1: A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants source ↗

Clinical trials (lead sponsor) 8

RecordTitlePhaseStatusStartPrimary completion
NCT07110610Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants1CompletedSep 3, 2025Mar 8, 2026 (actual)
NCT06049095A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants1Active, not recruitingOct 17, 20232026-09 (estimated)
NCT06774625This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third MolarsPhase 2CompletedDec 19, 2024Aug 8, 2025 (actual)
NCT07102459An Efficacy and Safety Study of LTG-001 Following AbdominoplastyPhase 2CompletedJul 24, 2025Jan 7, 2026 (actual)
NCT07341152A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy ParticipantsPhase 1CompletedOct 6, 2025Nov 17, 2025 (actual)
NCT06554574A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants1CompletedSep 3, 2024Jun 16, 2025 (actual)
NCT06972212Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male AdultsEarly phase 1CompletedJun 4, 2025Jun 28, 2025 (actual)
NCT06600607Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male AdultsEarly phase 1CompletedOct 7, 2024Oct 27, 2024 (actual)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Open jobs 19

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Associate Director, ToxicologySan Francisco, CaliforniaNot statedOct 16, 2026Senior
Associate Director, Clinical PharmacologySan Francisco, CaliforniaNot statedOct 16, 2026Senior
Vice President / Senior Vice President, Human ResourcesSan Francisco, CaliforniaNot statedOct 16, 2026Executive
Senior Director, Patient Safety & PharmacovigilanceSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Associate Director/Principal Scientist, CMC Analytical ChemistrySan Francisco, CaliforniaNot statedOct 16, 2026Senior
Associate Director, BioanalysisSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Associate Director, Medical WritingThousand Oaks, CaliforniaNot statedOct 16, 2026Senior
Director/ Associate Director, Clinical Finance & AccountingSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Clinical Trial Associate (Late Phase)Thousand Oaks, CaliforniaNot statedOct 16, 2026Entry
Sr. Clinical Research AssociateThousand Oaks, CaliforniaNot statedOct 16, 2026Senior
Medical Director, Early Phase Clinical DevelopmentSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Accounting ManagerSan Francisco, CaliforniaNot statedOct 16, 2026Mid
Senior Medical Director, Medical AffairsSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Senior Director, Scientific CommunicationsSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Senior Director, Commercial DistributionSan Francisco, CaliforniaNot statedOct 16, 2026Senior
Project ManagerThousand Oaks, CaliforniaNot statedOct 16, 2026Mid
Sr. Director, Regulatory AffairsThousand Oaks, CaliforniaNot statedOct 16, 2026Senior
Associate Director, CMC Drug SubstanceThousand Oaks, CaliforniaNot statedOct 16, 2026Senior
Director, Field Medical Director/ MSL Field Director- PainSan Francisco, California, United StatesNot statedOct 16, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Feedback